温肾通络汤联合隔盐灸治疗特发性膜性肾病伴肾间质纤维化临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692

基金项目:

河南省中医药拔尖人才培养项目(豫卫中医函〔2021〕15号)


Clinical Study on Wenshen Tongluo Decoction Combined with Salt-Seperated Moxi⁃ bustion for Idiopathic Membranous Nephropathy Complicated with Renal Interstitial Fibrosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察在现代医学常规疗法基础上加用温肾通络汤联合隔盐灸治疗脾肾阳虚型特发性膜性肾 病伴肾间质纤维化的临床效果。方法:纳入2022年1月—2024年1月于濮阳市中医医院肾病科治疗的90例脾 肾阳虚型特发性膜性肾病伴肾间质纤维化患者作为研究对象,采用随机数字表法分为对照组与研究组各45例。 2组均予现代医学常规疗法治疗,研究组加予温肾通络汤联合隔盐灸治疗。2组均连续治疗3个月。治疗前后评 定2组患者的中医证候评分,检测24 h尿蛋白定量、肾病蛋白(Nephrin)、结缔组织生长因子(CTGF)、1型血 小板反应蛋白7A域、B淋巴细胞活化因子(BAFF)、M型磷脂酶A2受体、甘肽过氧化物酶(GSH-Px)、活性 氧(ROS)、层粘连蛋白、Th17细胞百分比、Treg细胞百分比,计算Th17/Treg比值。观察2组患者不良反应的 发生情况。比较2组的临床疗效。结果:治疗后,研究组总有效率高于对照组(P<0.05)。2组下肢浮肿、畏 寒怕冷、腰酸乏力、大便溏薄、面色少华、纳差腹胀评分及总分均较治疗前降低(P<0.05),研究组6项中医 证候评分及总分均低于对照组(P<0.05)。2组24 h尿蛋白定量、1型血小板反应蛋白7A域、M型磷脂酶A2受 体、Nephrin、层粘连蛋白、CTGF、BAFF、ROS水平与Th17/Treg比值均较治疗前降低(P<0.05);研究组以 上9项指标值均低于对照组(P<0.05)。2组GSH-Px水平均较治疗前升高(P<0.05),研究组GSH-Px水平高 于对照组(P<0.05)。2组在治疗期间均无明显不良反应产生。结论:在现代医学常规疗法基础上加用温肾通 络汤联合隔盐灸治疗脾肾阳虚型特发性膜性肾病伴肾间质纤维化患者,可调节免疫功能,改善肾小球滤过屏 障,减轻肾纤维化及肾损伤,缓解病情,提高临床疗效,安全性好。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Wenshen Tongluo Decoction combined with salt-separated moxibustion on idiopathic membranous nephropathy of spleen-kidney yang deficiency type complicated with renal interstitial fibrosis on the basis of routine therapy in modern medicine. Methods:A total of 90 patients with idiopathic membranous nephropathy of spleen-kidney yang deficiency type complicated with renal interstitial fibrosis treated in the Department of Nephrology,Chinese Medicine Hospital of Puyang from January 2022 to January 2024 were included as the study subjects, and divided into the control group and the study group according to the random number table method,with 45 cases in each group. The two groups were treated with routine therapy in modern medicine,and the study group was additionally treated with Wenshen Tongluo Decoction combined with salt-separated moxibustion. Both groups were treated for three months continuously. Before and after treatment, the traditional Chinese medicine syndrome scores in the two groups were evaluated;the levels of 24-hour urinary protein quantity,Nephrin,connective tissue growth factor (CTGF), thrombospondin type-1 domain-containing 7A, B-cell activating factor of the TNF family (BAFF) , M-type phospholipase A2 receptor, glutathione peroxidase (GSH-Px) , reactive oxygen species (ROS), laminin, Th17 cell percentage, Treg cell percentage were detected, and Th17/Treg ratio was calculated. Observed the occurrence of adverse reactions in the two groups. The clinical effects were compared between the two groups. Results:After treatment,the total effective rate in the study group was higher than that in the control group (P<0.05). The scores of edema of lower limbs,aversion to cold,soreness of waist and lack in strength,thin sloppy stool, pale face, poor appetite and abdominal distension and the total scores in the two groups were reduced when compared with those before treatment( P<0.05),and the above scores in the study group were lower than those in the control group (P<0.05). The levels of 24-hour urinary protein quantity, thrombospondin type-1 domaincontaining 7A, M-type phospholipase A2 receptor, Nephrin, laminin, CTGF, BAFF and ROS and the Th17/Treg ratio in the two groups were down-regulated when compared with those before treatment (P<0.05); the above nine indexes in the study group were lower than those in the control group (P<0.05). The GSH-Px levels in the two groups were elevated when compared with those before treatment (P<0.05), and the GSH-Px level in the study group was higher than that in the control group (P<0.05). There were no significant adverse reactions in the two groups during treatment. Conclusion: The combination use of Wenshen Tongluo Decoction and salt-separated moxibustion can improve the curative effect on idiopathic membranous nephropathy of spleen-kidney yang deficiency type complicated with renal interstitial fibrosis based on the routine therapy in modern medicine,which can regulate the inmune function, improve the glomerular filtration barrier, reduce the renal fibrosis and kidney injury and alleviate the condition with great safety.

    参考文献
    相似文献
    引证文献
引用本文

张少崇,王春芳,宋韶娜.温肾通络汤联合隔盐灸治疗特发性膜性肾病伴肾间质纤维化临床研究[J].新中医,2025,57(12):74-79

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-26
  • 出版日期:
文章二维码